The European Reference Networks (ERNs) were launched in 2017. They involve more than 900 highly specialised health care teams, located in more than 300 hospitals in 26 European countries. The main mission of the ERNs is to help patients with rare or low-prevalence complex diseases.
A disease is defined as rare when it affects fewer than one in 2 000 people, is serious, chronic and often life-threatening. Between 5 000 and 8 000 of rare diseases affect daily life of around 30 million people in the EU.
The ERN EpiCARE brings together highly specialized health centres (28 full members and 15 affiliated partners) in 24 European countries with expertise in rare and complex epilepsies.
If you are a healthcare professional and would like to refer a patient to us, or if you are a patient yourself, or a family member of a patient, please get in touch via our contact page.
To improve accessibility of detailed diagnostics to individuals of all ages with rare and complex epilepsies across Europe, including clinical evaluation and investigation.
To develop treatment protocols and monitor standardised outcomes of rare and complex epilepsies.
To improve awareness and accessibility to protocols for physicians and individuals with rare and complex epilepsies across Europe for treatment.
To enhance educational activities and training opportunities across Europe by interchange across the network.
To enhance opportunities for registries, and collaborative research for the benefit of individuals with rare and complex epilepsies across Europe.
The 33eENE will have as a transversal theme: the advances in the last 10 years in the several areas of epilepsy, taking place on 12 and 13 March, maintaining the already usual satellite symposia and conversations with the specialists of the IF responsibility.
Applicants from ERN Full Members or Affiliated Partners can submit WORKSHOP TOPICS on rare diseases research to obtain funds (25.000€) in order to conduct a …
The aim of the 3-year cycle EPIPED training course, endorsed between others by the ERN EPICARE, the ILAE EUROPE and the EPNS, is to reduce the geographical and knowledge gap by providing neurologists and child neurologists involved in epilepsy care the opportunity for a regular update on best treatment practices in children with epilepsies.
The concept of EPIPED is based on a 3-year cycle of independent annual training courses, developed specifically for child neurologists, physicians and epilepsy nurses caring for patients with epilepsy.
A limited number of plenary interactive sessions cover different aspects of treatment strategies in children with all types of epilepsies, particularly the rare and complex ones. Topics treated are related to pharmacology, pharmacodynamics, pharmacokinetics, genetics, analysis of AED trials, design of clinical trials, pre-surgical evaluation, optimal choice of AEDs, review of existing guidelines (ILAE, NICE, other), data on ketogenic diet, neurostimulation, indications for resective and palliative surgery, pharmacological treatments other than with AEDs, update on the development of targeted therapies. This link gives you access to the full program of the 3 years cycle: https://www.epiped-course.com/PROGRAM_a24.html
An important number of interactive modules allow participants, limited to 10-15 per group, to discuss with experts regarding the best clinical practices and therapeutic strategies. Participants, limited to 40-45, are offered the opportunity to also bring their own clinical cases for discussion of optimal treatment approaches. This educational activity is addressing the corresponding learning objectives of the ILAE curriculum (Blümcke et al 2019).
We are delighted to invite you to what will be the 8th Oxford Masterclass in Epileptology at Corpus Christi College, Oxford. The Masterclasses aim to tackle a difficult area of epileptology over the course of a day with renowned national and international speakers. We encourage the sessions to be interactive with time for discussion after each talk and over the tea/coffee and lunch breaks.
The theme this year is the transition of people with epilepsy.
We very much hope that you will be able to join us in Oxford!
The main objective of the 7th edition of the Advanced Epilepsy Course Bridging Basic with Clinical Epileptology is to train attendees to improve the critical competencies necessary to design an effective research project/activity in the field of epilepsy.
Reliable neuropathological work-up of epilepsy-associated brain lesions represents an important diagnostic value for the surgical management of patients with drug-resistant focal epilepsy. The international classification of epilepsies recognizes a large spectrum of brain lesions as potential predictors of disease progression and treatment response.
The 11th International Summer School for Neuropathology and Epilepsy Surgery is designed to enable participants to better recognize and classify various histopathological substrates of drug-resistant epilepsy. Topics related to the diagnosis and treatment of human focal epilepsies will be presented by internationally renowned faculty. Advanced hands-on histopathology training will be offered in small groups led by distinguished tutors who will review and discuss microscopy slides of selected cases with different staining protocols. Participants will also have the opportunity to present their own cases for discussion with the entire group. The workshop has been held in Germany, Brazil, USA and China since 2013, with the endorsement of the International League Against Epilepsy (ILAE).
28 full members and 15 affiliated partners in 24 countries
European Reference Networks (ERN) are virtual networks involving specialist healthcare providers across Europe. They aim to tackle complex or rare medical diseases or conditions that require highly specialised treatment and a concentration of knowledge and resources. The ERNs are part of a broader EU strategy to make the national and European health systems more efficient, accessible and resilient.